Tag Archives: Eli Lilly

Eli Lilly Agrees To Reduce And Cap Insulin Prices

The New York Times reports: The drug maker Eli Lilly and Company said on Wednesday that it would significantly reduce the prices of several of its lifesaving insulin products that are used by diabetes patients and whose prices Lilly has repeatedly increased in the past. Lilly also said it would cap at $35 a month what patients pay out of …

Read More »

FDA Approves Antibody Drug Given To Chris Christie

The New York Times reports: The Food and Drug Administration has granted emergency authorization of a Covid-19 treatment made by the American pharmaceutical company Eli Lilly that was given to Chris Christie, the former New Jersey governor, when he was infected with the coronavirus. The authorization, announced on Monday, applies only to people newly infected with the virus, and the …

Read More »

COVID Drug Trial Paused Over Safety Concerns [VIDEO]

CNBC reports: Eli Lilly’s late-stage trial of its leading monoclonal antibody treatment for the coronavirus has been paused by U.S. health regulators over potential safety concerns, the company confirmed to CNBC on Tuesday. “Safety is of the utmost importance to Lilly. We are aware that, out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has …

Read More »

Pharma Giant To Sell Generic Version Of Insulin Drug

The New York Times reports: The drugmaker Eli Lilly will begin selling a cheaper version of its most popular insulin, Humalog, in an effort to head off criticism about the rising costs of prescription drugs, the company said Monday. Lilly will begin selling an “authorized generic” of Humalog 100 for $137.35 per vial, a 50 percent discount off the list …

Read More »